Yoshiki Sugimura
Suzuka, 5130801, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research.
Journal: Journal of clinical medicine
Published: November 07, 2024
Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: August 06, 2021
Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer.
Journal: Medical sciences (Basel, Switzerland)
Published: March 19, 2021
A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: January 13, 2021
Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts.
Journal: Journal of cellular biochemistry
Published: November 30, 2020
A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy.
Journal: IJU case reports
Published: October 22, 2020
Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non-expressors early after living donor kidney transplantation: Effect of interleukin 6-induced suppression of the cytochrome P450 3A gene.
Journal: Basic & clinical pharmacology & toxicology
Published: August 04, 2020
Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: June 03, 2020
Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration.
Journal: Journal of clinical medicine
Published: August 16, 2019
Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 24, 2019
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: March 22, 2019
Last Updated: 09/26/2026